PUBLICATION

Development and validation of an automated high-throughput system for zebrafish in vivo screenings

Authors
Letamendia, A., Quevedo, C., Ibarbia, I., Virto, J.M., Holgado, O., Diez, M., Izpisúa Belmonte, J.C., and Callol-Massot, C.
ID
ZDB-PUB-120529-28
Date
2012
Source
PLoS One   7(5): e36690 (Journal)
Registered Authors
Izpisúa Belmonte, Juan Carlos, Quevedo, Celia
Keywords
none
MeSH Terms
  • Animals
  • Drug Evaluation, Preclinical*
  • Heart/drug effects
  • Neovascularization, Physiologic
  • Software
  • Zebrafish/embryology*
PubMed
22615792 Full text @ PLoS One
Abstract

The zebrafish is a vertebrate model compatible with the paradigms of drug discovery. The small size and transparency of zebrafish embryos make them amenable for the automation necessary in high-throughput screenings. We have developed an automated high-throughput platform for in vivo chemical screenings on zebrafish embryos that includes automated methods for embryo dispensation, compound delivery, incubation, imaging and analysis of the results. At present, two different assays to detect cardiotoxic compounds and angiogenesis inhibitors can be automatically run in the platform, showing the versatility of the system. A validation of these two assays with known positive and negative compounds, as well as a screening for the detection of unknown anti-angiogenic compounds, have been successfully carried out in the system developed. We present a totally automated platform that allows for high-throughput screenings in a vertebrate organism.

Genes / Markers
Figures
Show all Figures
Expression
Phenotype
Mutations / Transgenics
Human Disease / Model
Sequence Targeting Reagents
Fish
Antibodies
Orthology
Engineered Foreign Genes
Mapping